Do analysts recommend INS or KOO?

Kooth has a consensus price target of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher probable upside, analysts clearly believe Kooth is more favorable than Instem. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Instem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Kooth 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has preferable earnings & valuation, INS or KOO?

Kooth has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Instem £61.63M 0.00 £3.34M £0.14 N/A Kooth £63.29M 0.91 £4.00M £7.00 22.69

Is INS or KOO more profitable?

Instem has a net margin of 5.50% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Instem's return on equity. Company Net Margins Return on Equity Return on Assets Instem 5.50% 6.35% 4.62% Kooth 4.12% 8.84% 10.12%

Does the media favor KOO or COG?

In the previous week, Kooth and Kooth both had 1 articles in the media. Cambridge Cognition's average media sentiment score of 0.67 beat Kooth's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kooth 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cambridge Cognition 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate KOO or INHC?

Kooth presently has a consensus price target of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher possible upside, equities analysts clearly believe Kooth is more favorable than Induction Healthcare Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kooth 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Induction Healthcare Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts rate RENX or KOO?

Kooth has a consensus target price of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher probable upside, analysts clearly believe Kooth is more favorable than Renalytix. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Renalytix 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Kooth 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has stronger earnings & valuation, RENX or KOO?

Kooth has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Renalytix £3.30M 2.48 -£109.93M -£4.00 N/A Kooth £63.29M 0.91 £4.00M £7.00 22.69

Is RENX or KOO more profitable?

Kooth has a net margin of 4.12% compared to Renalytix's net margin of -680.00%. Renalytix's return on equity of 274.67% beat Kooth's return on equity. Company Net Margins Return on Equity Return on Assets Renalytix -680.00% 274.67% -93.54% Kooth 4.12% 8.84% 10.12%

Do analysts rate FDBK or KOO?

Kooth has a consensus price target of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher probable upside, analysts plainly believe Kooth is more favorable than Feedback. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Feedback 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Kooth 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has higher valuation & earnings, FDBK or KOO?

Kooth has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Feedback £849.62K 3.74 -£10.84M -£15.74 N/A Kooth £63.29M 0.91 £4.00M £7.00 22.69

Is FDBK or KOO more profitable?

Kooth has a net margin of 4.12% compared to Feedback's net margin of -845.25%. Kooth's return on equity of 8.84% beat Feedback's return on equity. Company Net Margins Return on Equity Return on Assets Feedback -845.25% -135.17% -22.99% Kooth 4.12% 8.84% 10.12%

Kooth (KOO) Competitors

GBX 158.80 +0.80 (+0.51%)

As of 12:14 PM Eastern

Compare

KOO vs. INS, COG, INHC, RENX, and FDBK

Should you buy Kooth stock or one of its competitors? MarketBeat compares Kooth with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Kooth include Instem (INS), Cambridge Cognition (COG), Induction Healthcare Group (INHC), Renalytix (RENX), and Feedback (FDBK). These companies are all part of the "health information services" industry.

How does Kooth compare to Instem?

Instem (LON:INS) and Kooth (LON:KOO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

Kooth has higher revenue and earnings than Instem. Instem is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Instem	£61.63M	0.00	£3.34M	£0.14	N/A
Kooth	£63.29M	0.91	£4.00M	£7.00	22.69

Instem has a beta of 0.42, suggesting that its stock price is 58% less volatile than the broader market. Comparatively, Kooth has a beta of 1.298, suggesting that its stock price is 30% more volatile than the broader market.

Kooth has a consensus price target of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher probable upside, analysts clearly believe Kooth is more favorable than Instem.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Instem	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Instem has a net margin of 5.50% compared to Kooth's net margin of 4.12%. Kooth's return on equity of 8.84% beat Instem's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Instem	5.50%	6.35%	4.62%
Kooth	4.12%	8.84%	10.12%

65.9% of Instem shares are owned by institutional investors. Comparatively, 21.0% of Kooth shares are owned by institutional investors. 30.0% of Instem shares are owned by insiders. Comparatively, 30.4% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Kooth had 1 more articles in the media than Instem. MarketBeat recorded 1 mentions for Kooth and 0 mentions for Instem. Instem's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.

Company	Overall Sentiment
Instem	Neutral
Kooth	Neutral

Summary

Kooth beats Instem on 11 of the 14 factors compared between the two stocks.

How does Kooth compare to Cambridge Cognition?

Kooth (LON:KOO) and Cambridge Cognition (LON:COG) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, risk, institutional ownership, earnings, dividends and analyst recommendations.

In the previous week, Kooth and Kooth both had 1 articles in the media. Cambridge Cognition's average media sentiment score of 0.67 beat Kooth's score of 0.00 indicating that Cambridge Cognition is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Kooth	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cambridge Cognition	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Kooth presently has a consensus target price of GBX 330, suggesting a potential upside of 107.81%. Cambridge Cognition has a consensus target price of GBX 56, suggesting a potential upside of 62.79%. Given Kooth's higher possible upside, equities analysts clearly believe Kooth is more favorable than Cambridge Cognition.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Cambridge Cognition	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

21.0% of Kooth shares are held by institutional investors. Comparatively, 15.9% of Cambridge Cognition shares are held by institutional investors. 30.4% of Kooth shares are held by company insiders. Comparatively, 3.3% of Cambridge Cognition shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Kooth has higher revenue and earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kooth	£63.29M	0.91	£4.00M	£7.00	22.69
Cambridge Cognition	£9.40M	1.70	-£1.58M	-£3.90	N/A

Kooth has a beta of 1.298, indicating that its stock price is 30% more volatile than the broader market. Comparatively, Cambridge Cognition has a beta of 0.737, indicating that its stock price is 26% less volatile than the broader market.

Kooth has a net margin of 4.12% compared to Cambridge Cognition's net margin of -17.82%. Kooth's return on equity of 8.84% beat Cambridge Cognition's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kooth	4.12%	8.84%	10.12%
Cambridge Cognition	-17.82%	-62.89%	-0.30%

Summary

Kooth beats Cambridge Cognition on 12 of the 14 factors compared between the two stocks.

How does Kooth compare to Induction Healthcare Group?

Kooth (LON:KOO) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, media sentiment, analyst recommendations, dividends and profitability.

Kooth has higher revenue and earnings than Induction Healthcare Group. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Kooth	£63.29M	0.91	£4.00M	£7.00	22.69
Induction Healthcare Group	£12.57M	0.72	-£5.12M	-£5.54	N/A

Kooth has a net margin of 4.12% compared to Induction Healthcare Group's net margin of -23.86%. Kooth's return on equity of 8.84% beat Induction Healthcare Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Kooth	4.12%	8.84%	10.12%
Induction Healthcare Group	-23.86%	-14.58%	-7.32%

21.0% of Kooth shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 30.4% of Kooth shares are held by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Kooth had 1 more articles in the media than Induction Healthcare Group. MarketBeat recorded 1 mentions for Kooth and 0 mentions for Induction Healthcare Group. Kooth's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company	Overall Sentiment
Kooth	Neutral
Induction Healthcare Group	Neutral

Kooth presently has a consensus price target of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher possible upside, equities analysts clearly believe Kooth is more favorable than Induction Healthcare Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Induction Healthcare Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Kooth has a beta of 1.298, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, Induction Healthcare Group has a beta of -0.41, suggesting that its stock price is 141% less volatile than the broader market.

Summary

Kooth beats Induction Healthcare Group on 13 of the 15 factors compared between the two stocks.

How does Kooth compare to Renalytix?

Renalytix (LON:RENX) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, valuation, risk, institutional ownership, profitability, media sentiment and dividends.

14.0% of Renalytix shares are owned by institutional investors. Comparatively, 21.0% of Kooth shares are owned by institutional investors. 5.1% of Renalytix shares are owned by insiders. Comparatively, 30.4% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Kooth has a net margin of 4.12% compared to Renalytix's net margin of -680.00%. Renalytix's return on equity of 274.67% beat Kooth's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Renalytix	-680.00%	274.67%	-93.54%
Kooth	4.12%	8.84%	10.12%

In the previous week, Kooth had 1 more articles in the media than Renalytix. MarketBeat recorded 1 mentions for Kooth and 0 mentions for Renalytix. Renalytix's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.

Company	Overall Sentiment
Renalytix	Neutral
Kooth	Neutral

Renalytix has a beta of 1.808, indicating that its stock price is 81% more volatile than the broader market. Comparatively, Kooth has a beta of 1.298, indicating that its stock price is 30% more volatile than the broader market.

Kooth has higher revenue and earnings than Renalytix. Renalytix is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Renalytix	£3.30M	2.48	-£109.93M	-£4.00	N/A
Kooth	£63.29M	0.91	£4.00M	£7.00	22.69

Kooth has a consensus target price of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher probable upside, analysts clearly believe Kooth is more favorable than Renalytix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Renalytix	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Kooth beats Renalytix on 12 of the 15 factors compared between the two stocks.

How does Kooth compare to Feedback?

Feedback (LON:FDBK) and Kooth (LON:KOO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, dividends, risk, institutional ownership, profitability and valuation.

In the previous week, Kooth had 1 more articles in the media than Feedback. MarketBeat recorded 1 mentions for Kooth and 0 mentions for Feedback. Feedback's average media sentiment score of 0.00 equaled Kooth'saverage media sentiment score.

Company	Overall Sentiment
Feedback	Neutral
Kooth	Neutral

Kooth has a consensus price target of GBX 330, indicating a potential upside of 107.81%. Given Kooth's stronger consensus rating and higher probable upside, analysts plainly believe Kooth is more favorable than Feedback.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Feedback	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Kooth	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Kooth has higher revenue and earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Kooth, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Feedback	£849.62K	3.74	-£10.84M	-£15.74	N/A
Kooth	£63.29M	0.91	£4.00M	£7.00	22.69

Feedback has a beta of 0.77, indicating that its stock price is 23% less volatile than the broader market. Comparatively, Kooth has a beta of 1.298, indicating that its stock price is 30% more volatile than the broader market.

34.7% of Feedback shares are owned by institutional investors. Comparatively, 21.0% of Kooth shares are owned by institutional investors. 8.0% of Feedback shares are owned by insiders. Comparatively, 30.4% of Kooth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Kooth has a net margin of 4.12% compared to Feedback's net margin of -845.25%. Kooth's return on equity of 8.84% beat Feedback's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Feedback	-845.25%	-135.17%	-22.99%
Kooth	4.12%	8.84%	10.12%

Summary

Kooth beats Feedback on 13 of the 15 factors compared between the two stocks.

Get Kooth News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KOO vs. The Competition

Export

Metric	Kooth	Health Information Services Industry	Medical Sector	LON Exchange
Market Cap	£57.60M	£347.89M	£6.45B	£2.78B
Dividend Yield	N/A	5.60%	2.69%	6.16%
P/E Ratio	22.69	250.87	24.92	365.72
Price / Sales	0.91	132.06	528.81	86,253.69
Price / Cash	5.42	47.14	44.82	27.85
Price / Book	2.46	7.33	10.79	7.92
Net Income	£4.00M	-£22.78M	£3.56B	£5.89B
7 Day Performance	-1.79%	-0.92%	1.67%	-0.87%
1 Month Performance	-6.59%	1.59%	0.43%	-0.76%
1 Year Performance	-11.78%	-10.58%	32.84%	70.67%

Kooth Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KOO Kooth	1.9908 of 5 stars	GBX 158.80 +0.5%	GBX 330 +107.8%	-8.1%	£57.60M	£63.29M	22.69	478	News Coverage
INS Instem	N/A	N/A	N/A	N/A	£199.62M	£61.63M	5,928.57	500
COG Cambridge Cognition	1.7511 of 5 stars	GBX 35.04 -2.7%	GBX 56 +59.8%	-5.3%	£16.76M	£9.40M	N/A	80	Gap Up
INHC Induction Healthcare Group	N/A	GBX 9.75 flat	N/A	+0.0%	£9.00M	£12.57M	N/A	74
RENX Renalytix	N/A	GBX 1.98 +7.0%	N/A	-74.2%	£8.08M	£3.30M	N/A	102	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:KOO) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Kooth (KOO) Competitors